Sort
326,823 grants matching “clinical trial”
Dana-Farber/Harvard Cancer Center
$12,713,161Benjamin Levine Ebert · Dana-Farber Cancer Inst · P30 · FY2024 · CA
Dana-Farber/Harvard Cancer Center
$12,713,161Laurie H Glimcher · Dana-Farber Cancer Inst · P30 · FY2023 · CA
Dana-Farber/Harvard Cancer Center
$12,713,161Benjamin Levine Ebert · Dana-Farber Cancer Inst · P30 · FY2025 · CA
Dana-Farber/Harvard Cancer Center
$12,711,730Laurie H Glimcher · Dana-Farber Cancer Inst · P30 · FY2022 · CA
Production of a Broadly Neutralizing HIV Antibodies
$12,709,669Frank Arnold · National Institute Of Allergy And Infectious Diseases · ZIB · FY2017 · AI
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
$12,701,831Michael David Hughes · Harvard School Of Public Health · UM1 · FY2014 · AI
STATISTICAL AND DATA MANAGEMENT CENTER
$12,701,030Harvard University (Sch Of Public Hlth) · U01 · FY2005 · AI
ECOG-ACRIN NCORP Research Base
$12,699,758Lynne I. Wagner · Ecog-Acrin Medical Research Foundation · UG1 · FY2017 · CA
Clinical Acceptance of the Artificial Pancreas: the International Diabetes Closed Loop (iDCL) Trial
$12,653,694Boris P. Kovatchev · University Of Virginia · UC4 · FY2016 · DK
CoVPN 3008 2022-2023
$12,647,369Peter B. Gilbert · Fred Hutchinson Cancer Center · UM1 · FY2023 · AI
ProNET: Psychosis-Risk Outcomes Network
$12,623,656Scott W Woods · Yale University · U01 · FY2021 · MH
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
$12,618,678Bradley F Boeve · Mayo Clinic Rochester · U19 · FY2023 · AG
Production of a Broadly Neutralizing HIV Antibodies
$12,600,129Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2021 · AI
Statistics Center for Pediatric Type 2 Diabetes Therapy
$12,600,000George Washington University · U01 · FY2002 · DK
UF ADMIN COORDINATING CENTER
$12,596,951Marco Pahor · University Of Florida · U01 · FY2013 · AG
Data Coord. Center - NICHD Cooperative Multicenter Maternal Fetal Medicine Units
$12,596,715Elizabeth A Thom · George Washington University · U10 · FY2013 · HD
ECOG-ACRIN Network Group Operations Center
$12,592,885Peter J O'Dwyer · Ecog-Acrin Medical Research Foundation · U10 · FY2025 · CA
A Randomized, Double-Blind, Placebo-Controlled Study of LHP588 in Subjects with P. gingivalis-Positive Alzheimer's Disease
$12,591,952Michael J. Detke · Lighthouse Pharmaceuticals, Inc. · R01 · FY2025 · AG
STATISTICAL AND DATA MANAGEMENT CENTER
$12,587,388Harvard University (Sch Of Public Hlth) · U01 · FY2003 · AI
TAS::75 0885::TAS NIAID/DIVISION OF AIDS:CLINICAL SITE AND STUDY MONITORING
$12,573,195Michelle Vargas · Ppd Development Lp · N01 · FY2010 · AI
Immune Tolerance Network: Type 1 diabetes
$12,569,271Jeffrey Bluestone · University Of San Francisco · N01 · FY2010 · AI
Immune Monitoring and Analysis of Cancer at Stanford (IMACS)
$12,560,000Holden T. Maecker · Stanford University · U24 · FY2017 · CA
SWOG Network Group Operations Center of the NCTN
$12,554,242Charles D. Blanke · Oregon Health & Science University · U10 · FY2022 · CA
Radiation Therapy Oncology Group
$12,534,580Walter John Curran · American College Of Radiology · U10 · FY2009 · CA
Vanderbilt Vaccine and Treatment Evaluation Unit
$12,509,936Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2020 · AI